Overview

E4Relief (Response to Estetrol in Life Improvement for MEnopausal-associated Hot Flushes)

Status:
Completed
Trial end date:
2018-01-22
Target enrollment:
Participant gender:
Summary
This dose-finding study is being conducted to select the daily oral dose of estetrol (E4) for the treatment of vasomotor symptoms (VMS) in post-menopausal women.
Phase:
Phase 2
Details
Lead Sponsor:
Donesta Bioscience
Collaborators:
Chiltern International Inc.
SynteractHCR